Drugs / PF-04805712
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00991016 | Oct 2009 → Aug 2010 | — | Pfizer | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-04805712 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00991016 ↗ |
| Route | Oral | “Orally Administered PF-04805712” NCT00991016 ↗ |